CSBR vs HAL · P/E 16, rev $56.9M vs P/E 9.3, $19.05B cap
Champions Oncology Inc (CSBR) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
HAL does not have a complete income-statement cache yet.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the CSBR and HAL stock pages for the full models.
Not investment advice.